Scholarlink

Purpose <p>Active cholangiocytes featured with massive proliferation activate hepatic stellate cells (HSCs) and could cause eventual liver fibrosis (LF), however, this crosstalk still remains unclear in biliary atresia (BA). We aimed to evaluate the involvement of cancer susceptibility candidate 15 (<i>CASC15</i>) in BA.</p> Methods <p>Cholangiocyte organoid culture and sequencing was used to identify differentially expressed long noncoding RNA associated with cholangiocyte proliferation. The expression level of <i>CASC15</i> were detected in liver tissues. The CCK-8, EdU assay, co-culture experiments, and subcellular fractionation were employed to investigate its function and subcellular localization. Chromatin isolation by RNA purification coupled with mass spectrometry, RNA immunoprecipitation, and RNA sequencing were utilized to clarify the underlying mechanism of <i>CASC15</i>.</p> Results <p><i>CASC15</i> showed increased expression in cholangiocyte organoids and liver tissues of BA patients. Overexpressed <i>CASC15</i> in cholangiocytes enhanced cell proliferation and promoted HSC activation <i>in vitro</i>. <i>CASC15</i> predominantly located in the nucleus and was identified to interact with heterogeneous nuclear ribonucleoprotein U (HNRNPU) to maintain the expression of downstream target insulin-like growth factor binding protein 3 (IGFBP3), which could facilitate in the activation of HSCs.</p> Conclusion <p>This research revealed the crucial role of <i>CASC15</i>/HNRNPU-IGFBP3 regulatory network in the pathogenesis of LF in BA.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

CASC15 Promotes Cholangiocyte Proliferation and Liver Fibrosis by Regulating the HNRNPU-IGFBP3 Axis in Biliary Atresia

  • 期刊论文

  • 发表日期：

    2026年2月13日

查看全文
  • Yao Lu,
  • Zhongxian Zhu,
  • Yufei Zhu,
  • Wei Zhu,
  • Ruyi Zhang,
  • Zequan Ding,
  • Hua Xie,
  • Weibing Tang

摘要

Purpose

Active cholangiocytes featured with massive proliferation activate hepatic stellate cells (HSCs) and could cause eventual liver fibrosis (LF), however, this crosstalk still remains unclear in biliary atresia (BA). We aimed to evaluate the involvement of cancer susceptibility candidate 15 (CASC15) in BA.

Methods

Cholangiocyte organoid culture and sequencing was used to identify differentially expressed long noncoding RNA associated with cholangiocyte proliferation. The expression level of CASC15 were detected in liver tissues. The CCK-8, EdU assay, co-culture experiments, and subcellular fractionation were employed to investigate its function and subcellular localization. Chromatin isolation by RNA purification coupled with mass spectrometry, RNA immunoprecipitation, and RNA sequencing were utilized to clarify the underlying mechanism of CASC15.

Results

CASC15 showed increased expression in cholangiocyte organoids and liver tissues of BA patients. Overexpressed CASC15 in cholangiocytes enhanced cell proliferation and promoted HSC activation in vitro. CASC15 predominantly located in the nucleus and was identified to interact with heterogeneous nuclear ribonucleoprotein U (HNRNPU) to maintain the expression of downstream target insulin-like growth factor binding protein 3 (IGFBP3), which could facilitate in the activation of HSCs.

Conclusion

This research revealed the crucial role of CASC15/HNRNPU-IGFBP3 regulatory network in the pathogenesis of LF in BA.